Percheron Therapeutics Limited (ASX:PER)
Australia · Delayed Price · Currency is AUD 0.0030
-0.0005 (-14.29%)
Jul 10, 2026, 3:32 PM AEST
Percheron Therapeutics Market Cap
Percheron Therapeutics has a market cap or net worth of 5.33 million as of July 10, 2026. Its market cap has decreased by -51.00% in one year.
Market Cap
5.33M
Enterprise Value
882.87K
Revenue
1.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since December 20, 2001, Percheron Therapeutics's market cap has decreased from 26.10M to 5.33M, a decrease of -79.58%. That is a compound annual growth rate of -6.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 5.33M | -45.56% |
| Dec 31, 2025 | 9.79M | 28.57% |
| Dec 31, 2024 | 7.61M | -85.69% |
| Dec 29, 2023 | 53.19M | -18.04% |
| Dec 30, 2022 | 64.90M | -50.23% |
| Dec 31, 2021 | 130.40M | 74.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syntara | 45.12M |
| Peak Processing | 19.73M |
| Vitura Health | 18.56M |
| IDT Australia | 13.68M |
| Epsilon Healthcare | 8.56M |
| ECS Botanics Holdings | 7.98M |
| Argent BioPharma | 7.56M |
| Cann Group | 6.50M |